Patients with severe melanoma who received the treatment were 49% less likely to die or have their cancer return, ...

High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell ...

Pancreatic cancer is a rare disease; however, its initially inconspicuous symptoms and aggressive nature make it one of the ...

Scientists at Duke-NUS Medical School and the National University Health System (NUHS), together with an international team ...

Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...

We currently know that COPD, and specifically emphysema, is not just a lung disease found alongside lung cancer; it increases ...

Eating more anti-inflammatory and antioxidant-rich foods may slow biological aging and help reduce the risk of skin cancer, according to a study published in Cancers.1 ...

BostonGene, a leader in AI-powered solutions for drug discovery and development, is transforming how pharmaceutical companies develop, target, and deliver cancer therapies — making precision medicine ...

Global cancer cases have surged dramatically, doubling since 1990 and reaching 18.5 million new diagnoses in 2023. Deaths ...

"Guardant and MSD collaborate on companion diagnostics development" was originally created and published by Hospital ...

After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told ...

Ibuprofen may be doing more than easing aches and pains—it could also help reduce the risk of some cancers. Studies have ...